author

Author: Don Obrien

Poseida Therapeutics Promotes Finance Executive to CFO


By Dave Sebastian

Poseida Therapeutics Inc. said it has promoted Johanna Mylet, most recently the senior vice president of finance, to chief financial officer, effective Wednesday.

Ms. Mylet joined the company in 2015. She previously served as a controller at HUYA Bioscience International and an audit manager at Grant Thornton LLP.

The company, which went public in 2020, also tapped Devon Shedlock as its chief scientific officer for cell therapies and Lisa Portale as its senior vice president of regulatory affairs.

Write to Dave Sebastian at dave.sebastian@wsj.com



Source link

Share:

Share on facebook
Facebook
Share on twitter
Twitter
Share on pinterest
Pinterest
Oliver Bolt

Oliver Bolt

On Key

Related Posts